Financials

  • Market Capitalization 1.78 B
  • Employee 167
  • Founded 2019
  • CEO N/A
  • Website www.zenasbio.com
  • Headquarter Delaware, United States
  • FIGI BBG01J1MG9D6
  • Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-2.15
ratio cours/chiffre d'affaires

Related tickers

#NomPrix24h %7 jours %1M %1 an %Cap Boursière7 Derniers Jours
2076
RXRX
Recursion Pharmaceuticals, Inc. - Class A Common Stock
3.38 USD+1.20%-7.40%+3.36%-36.11%1.79 B USD
2077
PGEN
Precigen, Inc. - Common Stock
5.11 USD-0.20%-6.75%+6.24%+174.73%1.82 B USD
2117
IMCR
Immunocore Holdings plc - American Depositary Shares
33.60 USD+0.39%+1.94%+17.44%+0.36%1.71 B USD
2120
MRVI
Maravai LifeSciences Holdings, Inc. - Class A common stock
6.75 USD+3.69%+18.42%+36.09%+158.62%1.74 B USD